PMV Pharmaceuticals, Inc.
PMVPNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $60.33M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.02$1.91
- Volume (live)
- -
- Avg. volume (3M)
- 747.17K
PMV Pharmaceuticals (PMVP) Stock Price & Financial Analysis
PMV Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.10 - $1.29 |
|---|---|
| 52-Week High | $1.91 |
| 52-Week Low | $1.02 |
| Open | $1.26 |
| Volume (last close) | 648.58K |
| Average Volume (3M) | 747.17K |
| 50-Day MA | $1.38 |
|---|---|
| 200-Day MA | $1.30 |
| 1-Year Change | −17.41% |
| Market Cap | 60.33M |
|---|---|
| Shares Outstanding | 53.39M |
| Price to Book (P/B) | 0.84 |
| EV/EBITDA | -0.74 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
PMV Pharmaceuticals at a Glance
As of the Oct 26, 2026 close, PMV Pharmaceuticals (PMVP) has a market capitalization of $60.33M.
As of its latest reported balance sheet, it holds $12.47M in cash and securities against $217.00K of debt, a net cash position of $12.25M.
PMV Pharmaceuticals does not currently pay a dividend.
The share price is down 17.4% over the past year. At $1.13 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $1.02 to $1.91, below its 200-day moving average of $1.30.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $4.20, 271.7% above the Oct 26, 2026 close.
Frequently Asked Questions About PMV Pharmaceuticals
What is the current stock price for PMVP?
As of the Oct 26, 2026 close, PMVP stock trades at $1.13. The 52-week range is $1.02–$1.91, with a day range of $1.10–$1.28.
What is the P/E ratio for PMVP?
The P/E ratio (Price-to-Earnings) for PMVP is shown in the Key Statistics section. This valuation metric helps compare PMV Pharmaceuticals, Inc. to industry peers.
Does PMVP pay dividends?
PMV Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PMVP?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for PMVP is Buy. The average 12-month price target is $4.20, a 271.7% upside from the Oct 26, 2026 close of $1.13.
What is the market cap of PMVP?
As of the Oct 26, 2026 close, PMV Pharmaceuticals's market capitalization is $60.3M, classifying it as a micro-cap company. PMV Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.